Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Tuesday. The firm set a “hold” rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Stock Up 2.0 %

NYSE:MLSS opened at $1.02 on Tuesday. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.10. The firm’s fifty day simple moving average is $0.83 and its 200-day simple moving average is $0.84. The stock has a market cap of $79.45 million, a PE ratio of -14.57 and a beta of 1.08.

Insider Activity

In related news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. The trade was a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold a total of 109,193 shares of company stock worth $101,634 over the last 90 days. 24.75% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Milestone Scientific

Several hedge funds have recently bought and sold shares of the stock. World Investment Advisors LLC purchased a new position in Milestone Scientific in the 3rd quarter valued at about $91,000. Geode Capital Management LLC lifted its stake in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares during the period. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Milestone Scientific during the third quarter worth approximately $48,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.